The Red Light Report

Research: Red Light Therapy For Childhood Myopia / Primary Mitochondrial Diseases; Introducing BioBlue (SR)

May 16, 2024

50:51

It's about time that we dig back into some photobiomodulation research. This week we will take a deep dive into the impact of repeated low level red light therapy on childhood myopia. With an ever-increasing divergence of time that children spend viewing near-distance objects like phones, tablets, computers, TVs, etc. compared to time outside where the eyes have to focus on objects in the distance, this condition in particular is quickly on the rise and becoming an epidemic of its own. So if something as simple, safe and effective as red light therapy can help combat, mitigate and even reverse myopia, who wouldn't want to have this tool in their toolbox for their kid(s) and/or for themselves?!

Next we will visit an abstract that looks at primary mitochondrial diseases and how bioenergetics, oxidative stress and neuroinflammation all play a potential role. Sounds to me like The Mitochondrial Triad has a potentially large role to play here, as they can all positively impact those three variables and undoubtedly improve the function of the mitochondria. Red light therapy, methylene blue and C60 — a mitochondrion's delight!

Lastly, I introduce the newest version of BioLight's BioBlue. BioBlue (SR) is the very first supplement of its kind, consisting of a 50/50 blend of methylene blue and leucomethylene blue that provides the best of both worlds and delivers a Sustained Release of the mitochondrial-boosting properties of these blue molecules. Learn more about the benefits of this BioBlue concoction and why it was created!
If you found the information in today's episode particularly interesting and/or compelling, please share it with a family member, friend, colleague and/or anyone that you think could benefit and be illuminated by this knowledge. Sharing is caring :)

As always, light up your health! -

Key points:

Introduction (00:00:00 - 00:00:44)
Focus on red light therapy. (00:00:44 - 00:01:58)
BioBlue release announcement, positive reception of BioCream, uses discussed. (00:01:58 - 00:03:44)
Research on red light therapy for myopia in children, its prevalence and impact. (00:03:44 - 00:06:20)
Overview of systematic review on red light therapy, myopia characteristics. (00:06:20 - 00:08:29)
Summary of red light therapy's impact on myopia, prevention techniques. (00:08:29 - 00:10:26)
Myopia treatments, potential benefits of red light therapy. (00:10:26 - 00:13:07)
Discussion on red light therapy's effects, supporting studies. (00:13:07 - 00:14:51)
Importance of eye health, research findings. (00:16:10 - 00:18:32)
Summary of research, positive outcomes, safety. (00:18:32 - 00:21:14)
Mechanisms, comparison to other interventions. (00:21:14 - 00:23:57)
Long-term effects of discontinuing red light therapy. (00:25:05 - 00:25:25)
Meta-analysis highlights, benefits, low-intensity devices. (00:25:25 - 00:26:24)
Light irradiance importance, BioLight Glow mention. (00:26:24 - 00:28:49)
Mitochondrial diseases review, bioenergetics, oxidative stress. (00:28:49 - 00:33:20)
Summary of review, methylene blue benefits. (00:33:20 - 00:36:28)
Comparison between methylene blue types, BioBlue (SR). (00:36:28 - 00:39:09)
Combining methylene blue & leucomethylene blue for a sustained release. (00:39:09 - 00:42:37)
Importance of methylene blue quality, transparency. (00:42:37 - 00:44:15)
Further discussion on methylene blue, feedback encouragement. (00:44:15 - 00:49:39)
Closing statements, review encouragement, social media promotion. (00:49:39 - 00:50:23)